Changes between Version 8 and Version 9 of 041409NYCOptInWGAgenda


Ignore:
Timestamp:
03/30/09 15:29:37 (11 years ago)
Author:
hmussman@bbn.com
Comment:

--

Legend:

Unmodified
Added
Removed
Modified
  • 041409NYCOptInWGAgenda

    v8 v9  
    77The objective is to add content to the DRAFT document:  “GENI End-User Opt-In Overview”  (working title).
    88
    9 To date, five end-user opt-in use cases have been identified:
    10 
    11 •       Use Case 1:  User opt-in to GENI experiment for service
    12 •       Use Case 2:  Wholesale opt-in to GENI of traffic
    13 •       Use Case 3:  A disruptive GENI experiment
    14 •       Use Case 4:  Opt-in of user resources to a GENI experiment
    15 •       Use Case 5:  Gathering data involving opt-in users in a GENI experiment
    16 
    17 These use cases then drive requirements on capabilities that are being included into GENI, including:
    18 
    19 •       Capability 1:  Gateway from GENI to another network, e.g., the Internet
    20 •       Capability 2:  Contribution (or association) of a user’s node to an experiment on GENI
    21 •       Capability 3:  Gathering logs and experiment data on GENI (some possibly user-identifiable) and managing their distribution
    22 
    23 Finally, we expect various common policy themes to arise from an examination of the policies and best practices required for each use case, such as:
    24 
    25 •       Privacy policies for end-users
    26 •       Disclosure policies
    27 
    28 
    29 
    30 For each use case, we want to better understand and write down: 
    31         the players, their motivation and relationships;
    32         major issues (incentives, risks to consider, etc.)
    33         and a first cut at policies and best practices when operating in a GENI environment.
    34 
    35 
    36 We want to finish this meeting with a better understanding, and a few pages of text for each use case.  Then, we hope to have a baseline view of GENI opt-in that can be expanded in the coming months. 
     9We want to finish this meeting with a better understanding, and a baseline view of GENI opt-in that can be expanded in the coming months. 
    3710
    3811